在一个业余板球运动员中出现了一种不寻常的血栓风暴病例 - - 一份病例报告
Takshak Shankar1, Nagasubramanyam Vempalli2, Archana Bairwa1
1Department of Emergency Medicine, All India Institute of Medical Sciences, Rishikesh, India.
International journal of emergency medicine
|October 2, 2023
概括
血栓风暴,即一系列迅速发生的血块,需要及时识别和抗凝药. 早期治疗可以为经历多重血栓事件的患者挽救生命.
科学领域:
- 医学案例报告 病例报告
- 血管血栓形成症 血管血栓形成症
- 紧急医疗 紧急医疗
背景情况:
- 血栓风暴涉及几天到几周的急性至亚急性血栓事件.
- 诱导因素包括创伤或感染.
- 及时的抗凝剂对患者的生存至关重要.
研究的目的:
- 报告一个年轻,健康的男性患有血栓风暴的病例.
- 突出诊断和管理方面的挑战.
- 强调早期干预的重要性.
主要方法:
- 一个年轻男性患有动脉血栓和中风的病例报告.
- 诊断工作显示了高水平的同类半氨酸水平.
- 治疗包括抗凝药和试图进行血栓栓切除术.
主要成果:
- 患者经历了广泛的动脉血栓和脑中风.
- 血栓栓切除术没有成功.
- 最终需要进行肘下截肢.
结论:
- 血栓性风暴需要在急诊部立即进行识别.
- 及时启动抗凝药对于管理这种情况至关重要.
相关概念视频
Venous Thrombosis III: Interprofessional Care
10
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
10
Venous Thrombosis I: Introduction
12
Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
12
Anticoagulant Drugs: Low-Molecular-Weight Heparins
741
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
741
Disorders of Hemostasis
982
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
982
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
10
Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
10
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
1.2K
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
1.2K


